“If we can facilitate kidney stone passage without surgery, it allows our patients to avoid extra pain and risks that come with a surgical procedure,” says first author John M. Hollingsworth, M.D., associate professor of urology at the University of Michigan Medical School. “When the 2015 study(link is external) did not show a significant difference between alpha blockers and placebos, we wanted to explore the issue further.”
Click here to read the full release on the research.
